Osaic Holdings
VVOS icon

Osaic Holdings’s Vivos Therapeutics VVOS Stock Holding History

Osaic Holdings’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35K Hold
1,143
– – ﹤0.01% 7173
2025
Q4 		$2.32K Sell
1,143
-5,410
-83% -$13.4K ﹤0.01% 7050
2025
Q3 		$20.7K Buy
6,553
+5,760
+726% +$26.1K ﹤0.01% 5907
2025
Q2 		$2.5K Buy
793
+593
+297% +$1.5K ﹤0.01% 6851
2025
Q1 		$570 Sell
200
-393
-66% -$1.54K ﹤0.01% 6966
2024
Q4 		$2.54K Sell
593
-775
-57% -$2.59K ﹤0.01% 6508
2024
Q3 		$3.57K Buy
1,368
+470
+52% +$1.23K ﹤0.01% 6373
2024
Q2 		$1.99K Buy
+898
New +$2.19K ﹤0.01% 6597
2023
Q3 		– Sell
-40
Closed -$510 – 7551
2023
Q2 		$510 Buy
+40
New +$392 ﹤0.01% 7049

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Osaic Holdings's VVOS Position: Q1 2026 in Review

Osaic Holdings held its Vivos Therapeutics (VVOS) position steady in Q1 2026 at 1,143 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #7173.

Osaic Holdings first reported a position in VVOS in Q2 2023 and has held it in 9 quarters since. The position peaked at $20.7K in Q3 2025. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • Osaic Holdings held 1,143 shares of Vivos Therapeutics worth $1.35K as of Q1 2026.
  • Osaic Holdings left its Vivos Therapeutics share count unchanged in Q1 2026.
  • Vivos Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7173 holding.
  • Osaic Holdings first reported a position in Vivos Therapeutics in Q2 2023 and has held it in 9 quarters since.
  • Osaic Holdings's Vivos Therapeutics position peaked at $20.7K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.